Stocklytics Platform
Asset logo for symbol PBYI
Puma Biotechnology
High Value
Penny Stock
Asset logo for symbol PBYI



AI Deep-Learning Forecast (PBYI)

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Puma Biotechnology (PBYI) Stocklytics Forecast

According to the latest stock price predictions, PBYI, the ticker symbol for Puma Biotechnology Inc, is expected to experience significant growth in the coming years. Analysts forecast a promising future for this biotechnology company, which specializes in developing innovative cancer treatments. Machine learning algorithms and advanced AI technologies support these predictions.

Based on historical and current market trends, PBYI stock is expected to reach new highs in the next few years. Experts predict that by 2023, the stock price will experience a substantial increase. This positive outlook is reinforced by the analysts' price targets, which indicate a strong buy recommendation for Puma Biotechnology Inc. Investors are advised to consider adding PBYI stock to their portfolios based on these market projections and analyst ratings.

add Puma Biotechnology  to watchlist

Keep an eye on Puma Biotechnology

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

What is the AI price prediction for Puma Biotechnology (PBYI) stock?

At present, there is no AI or machine-learning-based price prediction available for Puma Biotechnology (PBYI) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

What is the analyst price prediction for Puma Biotechnology (PBYI) stock?

Analysts have set a target price of $11.93 for Puma Biotechnology (PBYI), based on forecasts from 14 analysts. The predicted price range extends from a high of $70 to a low of $6. This represents a potential increase of up to 1.81K% and a decrease of 63.93% from the current price of $3.66. These forecasts are as of 2019 Jan 03.

What are the analyst ratings for Puma Biotechnology (PBYI) stock?

The analyst ratings for Puma Biotechnology (PBYI) are distributed as follows: 8 analysts recommend buying, 1 have a neutral stance, and 0 suggest selling. The prevailing sentiment among the total of 9 analysts leans towards a buy rating. These ratings indicate the general sentiment among the analysts covering Puma Biotechnology .


Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level